Gut and Liver

The Korean Association for the Study of the Liver (대한간학회)
권호 표지
DOI QR코드

DOI QR Code

Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice

  • Jo, Hannah (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Eom, Young Woo (Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine) ;
  • Kim, Hyun-Soo (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Park, Hong Jun (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Kim, Hee Man (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Cho, Mee-Yon (Department of Pathology, Yonsei University Wonju College of Medicine)
  • Received : 2018.02.01
  • Accepted : 2018.04.23
  • Published : 2018.11.15
⟨ Previous Next ⟩

Abstract

Background/Aims: Regulatory dendritic cells (rDCs), which can be induced by mesenchymal stem cells (MSCs), play an important role in inducing and maintaining homeostasis of regulatory T cells and exhibit anti-inflammatory functions. In this study, we investigated whether MSCs could differentiate DCs into rDCs and compared the therapeutic effects of rDCs and MSCs on dextran sodium sulfate (DSS)-induced chronic colitis mice. Methods: Immature DCs (imDCs) and lipopolysaccharide (LPS)-treated mature DCs (mDCs) were co-cultured with MSCs for 48 hours, and then the profiles of surface markers and cytokines and regulatory roles of these DCs for primary splenocytes were analyzed. In addition, the therapeutic effects of MSCs and DCs co-cultured with MSCs were compared in chronic colitis mice. Results: After co-culture of imDCs (MSC-DCs) or LPS-treated mDCs (LPS+MSC-DCs) with MSCs, the expression of CD11c, CD80, CD86, interleukin 6 (IL-6), tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), and interferon-${\gamma}$ (IFN-${\gamma}$), was decreased, but that of CD11b, IL-10, and transforming growth factor-${\beta}$ (TGF-${\beta}$) was increased. Furthermore, MSC-DCs and LPS+MSC-DCs induced the expression of CD4, CD25, and Foxp3 in primary splenocytes isolated from mice. In DSS-induced colitis mice, MSCs and MSC-DCs increased colon length, body weight, and survival rate and induced histological improvement. Moreover, in the colon tissues, the expression of IL-6, TNF-${\alpha}$, and IFN-${\gamma}$ decreased, but that of IL-10, TGF-${\beta}$, and Foxp3 increased in the MSC- and MSC-DC-injected groups. Conclusions: Our data suggest that MSCs differentiate DCs into rDCs, which ameliorate chronic colitis. Thus, rDCs stimulated by MSCs may be therapeutically useful for the treatment of chronic inflammatory diseases.

Keywords

Acknowledgement

Supported by : Yonsei University Wonju College of Medicine

References

  1. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014;20:91-99. https://doi.org/10.3748/wjg.v20.i1.91
  2. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533. https://doi.org/10.1038/nri1132
  3. Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 2015;7:556-567. https://doi.org/10.4252/wjsc.v7.i3.556
  4. Duijvestein M, van den Brink GR, Hommes DW. Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J Crohns Colitis 2008;2:99-106. https://doi.org/10.1016/j.crohns.2007.12.002
  5. Dalal J, Gandy K, Domen J. Role of mesenchymal stem cell therapy in Crohn's disease. Pediatr Res 2012;71(4 Pt 2):445-451. https://doi.org/10.1038/pr.2011.56
  6. Li W, Ren G, Huang Y, et al. Mesenchymal stem cells: a doubleedged sword in regulating immune responses. Cell Death Differ 2012;19:1505-1513. https://doi.org/10.1038/cdd.2012.26
  7. Figueroa FE, Carrion F, Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res 2012;45:269-277. https://doi.org/10.4067/S0716-97602012000300008
  8. Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-3844. https://doi.org/10.1182/blood-2003-04-1193
  9. Chen QQ, Yan L, Wang CZ, et al. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses. World J Gastroenterol 2013;19:4702-4717. https://doi.org/10.3748/wjg.v19.i29.4702
  10. Lee HJ, Oh SH, Jang HW, et al. Long-term effects of bone marrow-derived mesenchymal stem cells in dextran sulfate sodiuminduced murine chronic colitis. Gut Liver 2016;10:412-419.
  11. Liu WH, Liu JJ, Wu J, et al. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS One 2013;8:e55487. https://doi.org/10.1371/journal.pone.0055487
  12. Zhao ZG, Xu W, Sun L, et al. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest 2012;41:183-198. https://doi.org/10.3109/08820139.2011.607877
  13. Zhang B, Liu R, Shi D, et al. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 2009;113:46-57. https://doi.org/10.1182/blood-2008-04-154138
  14. Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 1995;55:1099-1104.
  15. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811. https://doi.org/10.1146/annurev.immunol.18.1.767
  16. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. https://doi.org/10.1146/annurev.immunol.21.120601.141040
  17. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002;80:477-483. https://doi.org/10.1046/j.1440-1711.2002.01115.x
  18. Joffre O, Nolte MA, Sporri R, Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009;227:234-247. https://doi.org/10.1111/j.1600-065X.2008.00718.x
  19. Bates J, Diehl L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol 2014;232:112-120. https://doi.org/10.1002/path.4277
  20. Chen L, Zhang W, Yue H, et al. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev 2007;16:719-731. https://doi.org/10.1089/scd.2007.0065
  21. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009;113:6576-6583. https://doi.org/10.1182/blood-2009-02-203943
  22. Sato K, Yamashita N, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versushost disease and leukemia relapse. Immunity 2003;18:367-379. https://doi.org/10.1016/S1074-7613(03)00055-4
  23. Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012;12:417-430. https://doi.org/10.1038/nri3227
  24. Rayudu V, Raju AB. Effect of Triphala on dextran sulphate sodium-induced colitis in rats. Ayu 2014;35:333-338. https://doi.org/10.4103/0974-8520.153787
  25. Zhu H, Guo ZK, Jiang XX, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010;5:550-560. https://doi.org/10.1038/nprot.2009.238
  26. Lin CS, Xin ZC, Dai J, Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: limitations and challenges. Histol Histopathol 2013;28:1109-1116.
  27. Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002;129:263-276. https://doi.org/10.1159/000067596
  28. Wallet MA, Sen P, Tisch R. Immunoregulation of dendritic cells. Clin Med Res 2005;3:166-175. https://doi.org/10.3121/cmr.3.3.166
  29. Sato K, Yamashita N, Baba M, Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003;101:3581-3589. https://doi.org/10.1182/blood-2002-09-2712
  30. Chen W. Tregs in immunotherapy: opportunities and challenges. Immunotherapy 2011;3:911-914. https://doi.org/10.2217/imt.11.79
  31. Chen ZM, O'Shaughnessy MJ, Gramaglia I, et al. IL-10 and TGFbeta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood 2003;101:5076-5083. https://doi.org/10.1182/blood-2002-09-2798

Cited by

  1. Tributyrin in Inflammation: Does White Adipose Tissue Affect Colorectal Cancer? vol.11, pp.1, 2019, https://doi.org/10.3390/nu11010110
  2. The role of the miR1976/CD105/integrin αvβ6 axis in vaginitis induced by Escherichia coli infection in mice vol.9, pp.1, 2018, https://doi.org/10.1038/s41598-019-50902-w
  3. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer vol.2020, pp.None, 2018, https://doi.org/10.1155/2020/7819824
  4. Sishen Pill Treatment of DSS-Induced Colitis via Regulating Interaction With Inflammatory Dendritic Cells and Gut Microbiota vol.11, pp.None, 2018, https://doi.org/10.3389/fphys.2020.00801
  5. TSG-6 in extracellular vesicles from canine mesenchymal stem/stromal is a major factor in relieving DSS-induced colitis vol.15, pp.2, 2020, https://doi.org/10.1371/journal.pone.0220756
  6. Ligustilide alleviates neurotoxicity in SH‐SY5Y cells induced by Aβ25‐35 via regulating endoplasmic reticulum stress and autophagy vol.35, pp.3, 2018, https://doi.org/10.1002/ptr.6925
  7. Transforming Growth Factor Beta 1 Affects Gastric Cancer Cell Proliferation, Migration, and Invasion by Regulating Phosphatase and Tensin Homolog vol.11, pp.4, 2021, https://doi.org/10.1166/jbt.2021.2578
  8. Crosstalk between immune cells and bone cells or chondrocytes vol.101, pp.no.pa, 2018, https://doi.org/10.1016/j.intimp.2021.108179
  9. Challenges and advances in clinical applications of mesenchymal stromal cells vol.14, pp.1, 2018, https://doi.org/10.1186/s13045-021-01037-x
  10. Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies vol.12, pp.1, 2018, https://doi.org/10.1186/s13287-021-02533-0